TrendFlares logo

Rigel Pharmaceuticals, Inc. (RIGL)

$13.69 0.44% $0.06 Healthcare

Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases. The company offers Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia. It also develops Fostamatinib that is in phase III clinical trial for the treatment of warm autoimmune hemolytic anemia; phase III clinical trial for the treatment of hospitalized COVID-19 patients; and phase III clinical trial for the treatment of COVID-19. In addition, the company is developing R289, an oral interleukin receptor associated kinase 1/4 inhibitor, which is in phase I clinical trial for autoimmune, inflammatory, and hematology-oncology diseases; and R552, a receptor-interacting serine/threonine-protein kinase 1 inhibitor that has completed phase I clinical trial for autoimmune and inflammatory diseases. It has research and license agreements with AstraZeneca AB for the development and commercialization of R256, an inhaled JAK inhibitor; BerGenBio AS for the development and commercialization of AXL inhibitors in oncology; and Daiichi Sankyo to develop murine double minute 2 inhibitors for solid and hematological malignancies, as well as license and supply agreement with Kissei Pharmaceutical Co., Ltd. to develop and commercialize Fostamatinib. The company also has a license agreement and strategic collaboration with Eli Lilly and Company to co-develop and commercialize R552 for various indications, including autoimmune and inflammatory diseases, as well as other non-central nervous system (non-CNS) disease development candidates. Rigel Pharmaceuticals, Inc. was incorporated in 1996 and is headquartered in South San Francisco, California.

$240.88M

Mr. Raul R. Rodriguez

165.00

South San Francisco, CA

Nov 29, 2000

-17.78

$-0.77

1.11

2.29

-31.50%

-3.94

-0.03

-5.59

1.24

1.93

-34.07%

185.94%

Neutral

Similar stocks (15)

Day One Biopharmaceuticals, Inc.

DAWN

$14.32 3.84%
Downtrend

Terns Pharmaceuticals, Inc.

TERN

$10.04 -1.67%
Uptrend

Inozyme Pharma, Inc.

INZY

$5.78 -0.52%
Uptrend

Acumen Pharmaceuticals, Inc.

ABOS

$2.58 5.74%
Downtrend

X4 Pharmaceuticals, Inc.

XFOR

$0.71 0.63%
Downtrend

Leap Therapeutics, Inc.

LPTX

$2.84 -1.39%
Neutral

Cidara Therapeutics, Inc.

CDTX

$11.72 0.86%
Downtrend

Immix Biopharma, Inc.

IMMX

$1.77 -0.56%
Downtrend

Reviva Pharmaceuticals Holdings, Inc.

RVPH

$1.31 -5.07%
Downtrend

Fortress Biotech, Inc.

FBIO

$1.84 -4.17%
Downtrend

Ocuphire Pharma, Inc.

OCUP

$1.46 9.40%
Downtrend

Elevation Oncology, Inc.

ELEV

$0.60 0.94%
Downtrend

Pieris Pharmaceuticals, Inc.

PIRS

$16.99 5.14%
Uptrend

Enveric Biosciences, Inc.

ENVB

$0.49 -0.02%
Downtrend

eFFECTOR Therapeutics, Inc.

EFTR

$0.04 12.50%
Downtrend

ETF Exposure (24)

Invesco NASDAQ Future Gen 200 ETF

QQQS

0.706%

$27.51 1.81%
Uptrend

iShares Micro-Cap ETF

IWC

0.06272%

$126.54 2.19%
Uptrend

Franklin U.S. Small Cap Multifactor Index ETF

FLQS

0.02%

$42.39 1.80%
Uptrend

iShares Russell 2000 Growth ETF

IWO

0.01465%

$285.77 2.18%
Uptrend

Vanguard Russell 2000 Growth Index Fund

VTWG

0.01%

$208.30 2.26%
Uptrend

Vanguard Russell 2000 Index Fund

VTWO

0.01%

$90.58 2.07%
Uptrend

iShares Russell 2000 ETF

IWM

0.00941%

$223.97 2.06%
Uptrend

iShares Russell 2000 Value ETF

IWN

0.00368%

$170.39 1.83%
Uptrend

ProShares Ultra Russell2000

UWM

0.003458675999914223%

$44.09 4.26%
Uptrend

ProShares UltraPro Russell2000

URTY

0.0017053730429350746%

$54.27 6.25%
Uptrend

ProShares Hedge Replication ETF

HDG

0.0014443856589414473%

$50.07 0.41%
Uptrend

iShares Russell 3000 ETF

IWV

0.0006%

$325.63 1.75%
Uptrend

Vanguard Balanced Index Fund Institutional Shares

VBAIX

0%

$49.96 1.07%
Uptrend

Vanguard Balanced Index Fund Admiral Shares

VBIAX

0%

$49.95 1.07%
Uptrend

Vanguard Balanced Index Fund

VBINX

0%

$49.94 1.05%
Uptrend

Vanguard Extended Market Index Fund Institutional Shares

VIEIX

0%

$138.77 2.02%
Uptrend

Vanguard Institutional Total Stock Market Index Fund Institutional Shares

VITNX

0%

$97.80 1.74%
Uptrend

Vanguard Institutional Total Stock Market Index Fund

VITPX

0%

$97.78 1.74%
Uptrend

Vanguard Total Stock Market Index Fund

VITSX

0%

$137.33 1.73%
Uptrend

Vanguard Russell 3000 Index Fund

VTHR

0%

$253.06 1.86%
Uptrend

Vanguard Total Stock Market Index Fund

VTI

0%

$282.05 1.69%
Uptrend

Vanguard Total Stock Market Index Fund

VTSAX

0%

$137.30 1.73%
Uptrend

Vanguard Russell 2000 Value Index Fund

VTWV

0%

$150.33 1.93%
Uptrend

Vanguard Extended Market Index Fund

VXF

0%

$182.92 2.00%
Uptrend